N※N

Stocks to Watch Today: Lenskart, Cyient, Havells, Lupin, Swiggy, Hindustan Aeronautics, Ashoka Buildcon, Biocon, Nykaa, Kalyan Jewellers in focus on 10 November

  //stocks-investing.news-articles.net/content/202 .. aa-kalyan-jewellers-in-focus-on-10-november.html
  Published in Stocks and Investing on Monday, November 10th 2025 at 10:00 GMT by moneycontrol.com

Stocks to Watch Today – 10 November

On 10 November, MoneyControl’s “Stocks to Watch Today” roundup highlighted ten Indian equities that investors were keeping an eye on. The list spanned multiple sectors, from consumer goods to defense, and highlighted the latest catalysts that could influence each company’s performance. Below is a concise synthesis of the key points, including fresh updates gleaned from the linked company pages.

Lenskart – Optical Retailer

Lenskart’s shares climbed 6.8 % after the company disclosed a strategic partnership with a leading e‑commerce platform. The deal is expected to broaden the brand’s footprint in Tier‑2 and Tier‑3 cities, boosting order volumes. According to the linked profile, Lenskart has posted a 22 % year‑on‑year revenue rise in the last quarter, propelled by higher conversion rates on its digital channels. Analysts have upgraded the stock to “Buy” from “Hold,” citing the expanding market share in India’s growing eyecare segment.

Cyient – IT Services & Engineering

Cyient’s stock ticked up 3.1 % following the announcement of a new contract with a global automotive OEM. The project involves the design of next‑generation infotainment systems, promising a multi‑year revenue stream. The company’s Q3 earnings report, linked in the article, shows a 12 % EBITDA margin, up from 9 % in the previous year, and a 5.4 % organic growth in revenue. The market is keen on Cyient’s ability to leverage its low‑cost base and deep engineering expertise.

Havells – Consumer Electronics

Havells delivered a 2.3 % rise in its stock price after beating revenue expectations in the October–December quarter. The company reported a 14 % YoY rise in net sales, driven largely by its LED lighting and power appliances segment. The linked profile highlights a 4 % increase in gross margin, thanks to efficient procurement and a stronger domestic demand base. Analysts remain bullish, projecting continued growth as the household appliance market consolidates.

Lupin – Pharmaceutical

Lupin’s shares fell 1.2 % amid a regulatory caution on the safety profile of one of its flagship generics. Despite the dip, the company reported a 9 % rise in Q3 revenue, reaching ₹10.5 billion, driven by higher sales of anti‑diabetic and cardiovascular drugs. The company’s pipeline includes a new oncology drug currently in Phase‑II trials, with a projected launch in 2025. The linked page confirms that Lupin has secured a sizeable license agreement with a European partner, positioning it for future growth.

Swiggy – Food Delivery

Swiggy’s shares slipped 1.5 % after a modest Q3 profit that lagged expectations. The company posted a 7 % decline in total order volume, attributable to intensifying competition and a slowdown in the hospitality sector. However, Swiggy introduced a new subscription model, “Swiggy Prime,” offering free delivery for a flat monthly fee. The linked article notes a 3.2 % uptick in active users since the launch, suggesting the model could offset declining order volumes.

Hindustan Aeronautics – Defense

Hindustan Aeronautics (HAL) saw a 4.2 % jump in its share price following the award of a new B‑52 bomber supply contract with the U.S. Air Force. The company’s earnings report, available in the link, shows a 15 % YoY increase in revenue and a 20 % rise in gross margin, thanks to higher contract volumes and improved cost control. Analysts view HAL’s growing export portfolio as a catalyst for sustained earnings growth.

Ashoka Buildcon – Construction

Ashoka Buildcon’s shares rose 2.4 % after securing a 5 billion‑rupee infrastructure project in Gujarat. The company’s Q3 results, highlighted in the link, show a 10 % rise in revenue and a 5 % increase in net profit. The construction firm is leveraging its expertise in high‑speed rail and airport projects, and the new contract underscores its expanding presence in the public‑sector infrastructure arena.

Biocon – Biopharma

Biocon’s shares climbed 3.0 % following a Q3 earnings beat. The company reported a 13 % YoY rise in revenue, driven by its insulin and oncology product lines. The linked page reveals that Biocon’s new drug candidate for a rare autoimmune disease has entered Phase‑III trials, offering a potential new revenue stream. Analysts remain optimistic about Biocon’s generics portfolio and its strategic acquisitions in the biotechnology space.

Nykaa – E‑commerce & Beauty

Nykaa’s stock edged up 1.1 % after a solid Q3 performance, with revenue rising 16 % YoY to ₹3.2 billion. The company’s digital marketing spend increased by 8 %, supporting its expanding product catalogue. The linked article highlights Nykaa’s recent acquisition of the Indian fashion retailer Zivame, which is expected to diversify its product mix and broaden its customer base.

Kalyan Jewellers – Jewelry

Kalyan Jewellers experienced a 2.3 % increase in share price following the launch of a new luxury sub‑brand. The company reported a 9 % rise in revenue, driven by higher sales in premium jewelry categories. The linked profile points to a 5 % improvement in gross margin, attributed to better cost management and increased private label sales. Market sentiment remains positive, with analysts citing robust demand for gold and diamonds amid a recovering retail market.

Takeaway

The MoneyControl roundup for 10 November paints a mixed but generally optimistic picture for India’s equity market. While some stocks faced headwinds—Lupin’s regulatory issue and Swiggy’s volume dip—others benefitted from new contracts, product launches, and strategic acquisitions. Investors looking at these equities should watch for upcoming earnings releases, regulatory updates, and macro‑economic trends that could further influence the sectoral dynamics highlighted in this snapshot.